SS Innovations International Inc (SSII)
4.01
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SS Innovations International SG&A Expense (Quarterly): 1.224M for Dec. 31, 2022
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 1.224M |
September 30, 2022 | 0.9001M |
June 30, 2022 | 0.17M |
March 31, 2022 | 0.0805M |
December 31, 2021 | 0.2764M |
September 30, 2021 | 0.4182M |
June 30, 2021 | 0.4114M |
March 31, 2021 | 0.3001M |
December 31, 2020 | 0.2001M |
September 30, 2020 | 0.3752M |
June 30, 2020 | 0.22M |
March 31, 2020 | 0.3047M |
December 31, 2019 | 1.000M |
September 30, 2019 | 1.386M |
Date | Value |
---|---|
June 30, 2019 | 0.5047M |
March 31, 2019 | 0.3703M |
December 31, 2018 | 0.211M |
September 30, 2018 | 0.2946M |
June 30, 2018 | 0.2013M |
March 31, 2018 | 0.2264M |
December 31, 2017 | 0.46M |
September 30, 2017 | 0.165M |
June 30, 2017 | 0.1738M |
March 31, 2017 | 0.1408M |
December 31, 2016 | 0.1399M |
September 30, 2016 | 0.1825M |
June 30, 2016 | 0.0125M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.0805M
Minimum
Mar 2022
1.386M
Maximum
Sep 2019
0.5181M
Average
0.3752M
Median
Sep 2020
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 5.878M |
Retractable Technologies Inc | 4.745M |
Xtant Medical Holdings Inc | 20.24M |
Asensus Surgical Inc | 8.016M |
Catheter Precision Inc | 2.656M |